Abstract
A series of novel β-chloro vinyl chalcones have been synthesized from substituted (Z) – 3 – chloro – 3- phenylacraldehydes with 1-(3 – bromo – 2 – hydroxyl-4,6- dimethoxyphenyl)ethanone by Claisen-Schmidt condensation reaction. Compounds were screened for anti-inflammatory, anticancer and antioxidant activity. Compounds 6a, 6d and 6f revealed promising anti-inflammatory activity (87 – 99 %) with less cytotoxicity (4 – 9 %) at 10 µ M. Compounds 6a, 6d, 6e and 6f having significant anticancer activity (71 – 83 %). Bioavailability of compounds were checked by in vitro cytotoxicity and confirmed to be nontoxic. Structure activity relationship and in silico drug relevant properties of compounds revealed as potential candidates for future drug discovery study.
Keywords: Anti-inflammatory activity, Anticancer activity, Antioxidant activity, In silico, luekotrienes, Claisen-Schmidt condensation reaction, Reactive oxygen species (ROS), cytotoxicity, Bioavailability, cytokines, TNF-α, atherosclerosis, rheumatoid arthritis (RA), haematopoiesis
Letters in Drug Design & Discovery
Title: Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity
Volume: 8 Issue: 8
Author(s): Babasaheb P. Bandgar, Baliram S. Hote and Shivraj H Nile
Affiliation:
Keywords: Anti-inflammatory activity, Anticancer activity, Antioxidant activity, In silico, luekotrienes, Claisen-Schmidt condensation reaction, Reactive oxygen species (ROS), cytotoxicity, Bioavailability, cytokines, TNF-α, atherosclerosis, rheumatoid arthritis (RA), haematopoiesis
Abstract: A series of novel β-chloro vinyl chalcones have been synthesized from substituted (Z) – 3 – chloro – 3- phenylacraldehydes with 1-(3 – bromo – 2 – hydroxyl-4,6- dimethoxyphenyl)ethanone by Claisen-Schmidt condensation reaction. Compounds were screened for anti-inflammatory, anticancer and antioxidant activity. Compounds 6a, 6d and 6f revealed promising anti-inflammatory activity (87 – 99 %) with less cytotoxicity (4 – 9 %) at 10 µ M. Compounds 6a, 6d, 6e and 6f having significant anticancer activity (71 – 83 %). Bioavailability of compounds were checked by in vitro cytotoxicity and confirmed to be nontoxic. Structure activity relationship and in silico drug relevant properties of compounds revealed as potential candidates for future drug discovery study.
Export Options
About this article
Cite this article as:
P. Bandgar Babasaheb, S. Hote Baliram and Nile Shivraj H, Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity, Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796576051
DOI https://dx.doi.org/10.2174/157018011796576051 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
Current Signal Transduction Therapy Neuronal Semaphorins Regulate a Primary Immune Response
Current Neurovascular Research Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued) Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
Current Topics in Medicinal Chemistry Drug Repositioning Based on a Multiplex Network by Integrating Disease, Gene, and Drug Information
Current Bioinformatics Advances in Interleukin-12 Gene Therapy for Acquired Liver Diseases
Current Gene Therapy Exosome: An Emerging Source of Biomarkers for Human Diseases
Current Molecular Medicine Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology Spacer Length: A Determining Factor in the Design of Galactosyl Ligands for Hepatoma Cell-Specific Liposomal Gene Delivery
Current Drug Delivery Antagonists of IAP Proteins: Novel Anti-Tumor Agents
Current Medicinal Chemistry Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers
Recent Patents on Anti-Cancer Drug Discovery Chalcones as Promising Lead Compounds on Cancer Therapy
Current Medicinal Chemistry Current and Future Clinical Strategies in Colon Cancer Prevention and the Emerging Role of Chemoprevention
Current Pharmaceutical Design Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Current Pharmaceutical Design Bifunctional Chelators in the Design and Application of Radiopharmaceuticals for Oncological Diseases
Current Medicinal Chemistry Exploring Optic Nerve Axon Regeneration
Current Neuropharmacology Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration
Current Pharmaceutical Design The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
Current Pharmaceutical Biotechnology